Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

The hydrogel speeds up skin wound healing and helps regenerate tissue.

The screening method effectively predicts psychosis, valproate use is linked to hair loss, and IDEAS is valid for assessing mental disorder disability.

AGA might indicate higher risk for severe COVID-19.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.

Self-assembling peptide hydrogels effectively deliver drugs locally, enhancing treatment and reducing side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Sodium valproate is effective in treating epilepsy, especially in patients who don't respond to other medications.

The herbal mix of hibiscus and vitex shows promise for treating autoimmune diseases due to its effectiveness and low toxicity.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

A reliable method was developed to measure aristolochic acid-I in rat blood.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.